Seeking Alpha

NPS Pharmaceuticals (NPSP +1.8%) trades higher after the FDA accepts its Gattex drug application...

NPS Pharmaceuticals (NPSP +1.8%) trades higher after the FDA accepts its Gattex drug application for review. Slicing through the firm's statement a bit - it appears that it didn't land a coveted "priority" review from the FDA.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)